DossierENTITY

Avalyn

Coverage of Avalyn in the Nexus archive.

Earliest in view: Apr 30 · 01:12 UTCMost recent: Apr 30 · 01:12 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHApr 30 · 01:12 UTCBLOOMBERG
Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO
Avalyn, a drugmaker backed by Novo, raised $300 million in an upsized IPO. Its drug AP01 has completed a clinical trial for idiopathic pulmonary fibrosis.